These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3845025)

  • 21. The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.
    Mokbel K; Ghilchik M; Williams G; Akbar N; Parris C; Newbold R
    Int J Surg Investig; 2000; 1(6):509-16. PubMed ID: 11729859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fine-needle aspiration biopsy and analysis of estrogen receptors in breast cancer].
    Benyahia B; Magdelenat H; Zajdela A; Vilcoq JR
    Bull Cancer; 1982; 69(5):456-60. PubMed ID: 7165807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of high speed biopsy gun in breast cancer diagnosis.
    Joshi PS; Badwe RA
    Indian J Cancer; 1999 Mar; 36(1):43-5. PubMed ID: 10810554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer.
    Garimella V; Long ED; O'Kane SL; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(2):204-7. PubMed ID: 17453370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
    Mauriac L; Wafflart J; Trojani M; Durand M
    Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytology of breast cancer correlated with biochemically determined hormone sensitivity].
    Yilmaz H; Labenski R; Jungblut PW; Ries P
    Verh Dtsch Ges Pathol; 1985; 69():549-51. PubMed ID: 4096125
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of histochemical and biochemical methods in the evaluation of estrogen and progesterone receptor level in human breast cancer. A study of 118 cases.
    Mohácsy J; Kádár A; Vallent K; Duffek L; Vass K
    Acta Chir Hung; 1988; 29(1):95-105. PubMed ID: 2455948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry].
    Marcot I; Migeon C; Parache RM; Marchal S; Virion JM
    Bull Cancer; 1997 Jun; 84(6):613-8. PubMed ID: 9295864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.
    Bhargava V; Kell DL; van de Rijn M; Warnke RA
    Am J Pathol; 1994 Sep; 145(3):535-40. PubMed ID: 8080038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of time and therapy on the hormone receptor status of breast carcinomas.
    Mobbs BG
    Can Med Assoc J; 1982 Aug; 127(3):217-21. PubMed ID: 6896673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
    Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions.
    Wood B; Junckerstorff R; Sterrett G; Frost F; Harvey J; Robbins P
    Pathology; 2007 Aug; 39(4):391-5. PubMed ID: 17676479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estrogen and progesterone receptors in cancer of the female breast: correlation with the age of the patients, fertility status, tumor stage and grading].
    Bracali G; De Magistris A; Olivieri D; Loli MG; Bracali M; Caracino AM; Marinucci R
    Pathologica; 1986; 78(1054):179-94. PubMed ID: 3822562
    [No Abstract]   [Full Text] [Related]  

  • 38. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
    Kasch R; Meissner J; Haack D; Neumann S
    Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.